Nuedexta Case Studies

532 Words2 Pages

Nuedexta® for Pseudobulbar Affect in an ALS Patient Pseudobulbar Affect (PBA) is a neurological condition that causes the patient to experience inappropriate and uncontrollable laughing and crying, which is an exaggeration of the emotions experienced or, in some instances, totally unrelated to the patient’s emotions. Episodes, which can last from seconds to several minutes, are often mistaken for mood disorders and can be disruptive to daily living (Mayo, 2017). Approximately 43 to 49 percent of ALS patients suffer from PBA (BCM, 2017). The target for change in this single subject design research was the number of episodes of PBA experienced by the participating ALS patient. The goal was to reduce the number of episodes with an intervention …show more content…

The observation points, days of the week, are marked on the x axis and the frequency of PBA episodes is plotted on the y axis. The visual analysis of this graph shows that the medication, Nuedexta®, reduced the number of PBA episodes for this patient. During the baseline period, episodes of PBA were stable as evidenced by the flat baseline trend. The patient was experiencing between 7 – 9 episodes of PBA daily prior to the introduction of the initial dose of Nuedexta®. When Nuedexta® was introduced once a day for 7 days during the initial intervention (B), PBA episodes decreased with the patient experiencing between 5 - 7 episodes per day. The patient’s PBA episodes dropped to between 2 – 4 episodes per day when Nuedexta® was increased to twice a day during intervention (C). The research suggests that the administration of Nuedexta® every 12 hours should be continued for this patient. Intervention C is the recommended dosage for Nuedexta®. Optimum results for this medication are generally achieved by week 12 (Avanir, 2017). Based on the level of improvement the patient has experienced after 3 weeks, Nuedexta® should be continued at the recommended

More about Nuedexta Case Studies

Open Document